NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Novocure did not provide their enrollment curve. They did not provide any further updates. The played games with extrapolation to the point that they claimed 29% survival in a subgroup of 43 where only one out of 43 patients actually lived to five years at data cutoff. They did not update this number even though they could have easily update the number alive forward by one year. Instead they hid the information and advertised in presentations that 29.3% patients that wore the device 22-24 hours a day lived to five years. Not mentioning that was from an actual sample of 1 patient alive at five years. You would probably want to know that if you were deciding which therapy to expend an additional $420,000 dollars on to live a median 4 months longer (50% chance) than you would with SOC. You'd probably want to know this if you are going to decide if it's worth wearing 24/7 and lugging around. If it's worth the side effects. My guess is you'd want to know.

Flipper44,

I can guess what Dr. Suriya Jeyapalan would tell her patients with glioblastoma.

Transforming Glioblastoma Management: A MasterClass on Evaluating Newer and Emerging Options in the Precision Medicine and Person-Centered Care Era.
http://media.peerviewpress.com/000136/podcast/pvi/m4v/150205223-2-2GWT.m4v